|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
157,644,000 |
Market
Cap: |
N/A |
Last
Volume: |
3,641,286 |
Avg
Vol: |
1,697,009 |
52
Week Range: |
$0.034 - $0.034 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Depinto Joseph I |
EVP, Global Commercial Ops |
|
2014-01-03 |
4 |
D |
$3.08 |
$29,124 |
D/D |
(9,456) |
123,022 |
|
- |
|
Frohlich Mark W |
EVP, R&D and CMO |
|
2014-01-03 |
4 |
D |
$3.08 |
$33,181 |
D/D |
(10,773) |
526,171 |
|
- |
|
Cox Greg |
VP, Interim CFO & Treasurer |
|
2014-01-03 |
4 |
D |
$3.08 |
$16,339 |
D/D |
(5,305) |
302,274 |
|
- |
|
Cox Greg |
VP, Interim CFO & Treasurer |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
307,579 |
|
- |
|
Monteith William |
EVP, Technical Operations |
|
2014-01-03 |
4 |
D |
$3.08 |
$29,124 |
D/D |
(9,456) |
343,509 |
|
- |
|
Monteith William |
EVP, Technical Operations |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
352,965 |
|
- |
|
Johnson John H |
Pres & Chief Executive Officer |
|
2014-01-03 |
4 |
D |
$3.08 |
$110,252 |
D/D |
(35,796) |
1,049,016 |
|
- |
|
Johnson John H |
Pres & Chief Executive Officer |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
395,189 |
1,084,812 |
|
- |
|
Cvijic Christine Mikail |
EVP, Corp Dev, Gen Cnsl/Scrtry |
|
2014-01-03 |
4 |
D |
$3.08 |
$29,124 |
D/D |
(9,456) |
339,676 |
|
- |
|
Cvijic Christine Mikail |
EVP, Corp Dev, Gen Cnsl/Scrtry |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
349,132 |
|
- |
|
Rocco Lindsay |
EVP, Corporate Communications |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
120,707 |
|
- |
|
Granadillo Pedro P |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
87,251 |
|
- |
|
Watson Douglas G |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
104,757 |
|
- |
|
Stump David C |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
82,047 |
|
- |
|
Urdal David |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
644,750 |
|
- |
|
Bayh Susan B |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
115,757 |
|
- |
|
Dziurzynskio Bogdan |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
103,507 |
|
- |
|
Fenton Dennis M |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
75,000 |
|
- |
|
Johnson John H |
Pres & Chief Executive Officer |
|
2013-12-31 |
4 |
D |
$2.99 |
$114,762 |
D/D |
(38,382) |
689,623 |
|
- |
|
Rocco Lindsay |
EVP, Corporate Communications |
|
2013-12-10 |
4 |
S |
$2.94 |
$24,145 |
D/D |
(8,207) |
112,500 |
|
- |
|
Depinto Joseph I |
EVP, Global Commercial Ops |
|
2013-12-08 |
4 |
D |
$3.01 |
$2,884 |
D/D |
(958) |
132,478 |
|
- |
|
Cvijic Christine Mikail |
EVP, Corp Dev, Gen Cnsl/Scrtry |
|
2013-12-08 |
4 |
D |
$3.01 |
$4,154 |
D/D |
(1,380) |
149,132 |
|
- |
|
Rocco Lindsay |
EVP, Corporate Communications |
|
2013-11-30 |
4 |
D |
$2.97 |
$12,750 |
D/D |
(4,293) |
45,707 |
|
- |
|
Schiffman Greogry T |
EVP |
|
2013-10-21 |
4 |
D |
$2.40 |
$768 |
D/D |
(320) |
441,924 |
|
- |
|
Frohlich Mark W |
EVP, R&D and CMO |
|
2013-10-21 |
4 |
D |
$2.40 |
$922 |
D/D |
(384) |
536,944 |
|
- |
|
721 Records found
|
|
Page 5 of 29 |
|
|